3billion

41 Patients Found New Answers Through Reanalysis of Genetic Testing: May 2026

Genetic test | 26. 05. 27

Is a single genetic test result the end of the diagnostic journey?
At 3billion, we believe diagnosis is an ongoing process. That’s why we focus not only on the test itself, but on what comes after:
Reanalysis.

For all cases previously reported as Inconclusive or Negative,
3billion performs automated reanalysis through a continuous system.
Each month, dozens of reports are updated, revealing new diagnostic insights and possibilities.

Summary of Diagnostic Changes This Month

In May 2026, a total of 41 patients received updated reports through reanalysis. 

Why did the results change?

51%: Algorithm improvement

24%: Variant database updates

20%: Disease database updates

5%: Additional phenotypes and information provided by ordering physician

This means that as clinical and scientific data evolve, the same patient data can lead to a different diagnosis over time.

A reanalysis system is essential for keeping pace with constantly evolving databases. 3billion automates this process to deliver results faster and at a more accessible cost.

So, how exactly does automated reanalysis work?

It continuously monitors the latest variant and disease databases, updates internal interpretation models, and incorporates new phenotype and family history data submitted by clinicians.

Diagnosis doesn’t end with a single report.

It continues as the knowledge base grows— and 3billion’s automated reanalysis system ensures patients benefit from that progress.

Get exclusive rare disease updates
from 3billion.

Soo-jung Baek

As a marketer, I strive to empower the rare disease community by sharing meaningful insights backed by our company’s expertise.

Read More from This Author

Recommended For You